معرفی
Diego Aguilar Rodriguez serves as a Researcher/Postdoc at University Medical Center Utrecht (UMC Utrecht), where he advances cutting-edge drug delivery technologies with emphasis on lipid nanoparticle systems for mRNA therapeutics. His work bridges pharmaceutical sciences and biomedical engineering to address critical challenges in cellular uptake and delivery efficiency.
Dr. Rodriguez's research program focuses on biomimetic approaches to nanomedicine, specifically incorporating cellular membrane components into delivery vehicles to enhance therapeutic payload transport. His methodology combines nanofabrication expertise with molecular biology techniques to engineer next-generation carriers for genetic medicines, with significant implications for vaccine development and gene therapy applications.
Analysis of his publication record reveals a concentrated focus on overcoming biological barriers in nucleic acid delivery. The 2025 Journal of Controlled Release paper demonstrates how membrane protein integration substantially improves nanoparticle performance, establishing a novel paradigm in delivery system design that prioritizes biological compatibility over conventional synthetic approaches.
While specific grant details aren't public, his active publication in a premier controlled-release journal indicates robust research momentum in nanomedicine. Prospective collaborators in pharmaceutical technology or mRNA therapeutics should note his expertise in translational delivery system development and strong institutional alignment with UMC Utrecht's ATMP initiatives.
